date:Sep 12, 2012
progress.
Parekh pointed out that many issues remain unsolved on the regulatory endfor example, labelling standards with regard to health claims. Standardisation is needed across the industry. Right now, we have a situation that sees us teaching our buyers about what they can put or not put on their labels.
Moreover, he added that the lack of a regulatory framework has also meant that a number of substandard nutraceuticals have been entering the market, with many smaller and regional players